Evoke Pharma Inc. sell StockNews.com
Start price
29.06.24
/
50%
€0.48
Target price
29.06.25
-
Performance (%)
-29.46%
End price
30.06.25
-
Summary
This prediction is currently being closed. The price of Evoke Pharma Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -29.46%. StockNews_com has a follow-up prediction for Evoke Pharma Inc. where he still thinks Evoke Pharma Inc. is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Evoke Pharma Inc. | - | - | - |
| iShares Core DAX® | 2.554% | 0.562% | 14.142% |
| iShares Nasdaq 100 | 2.742% | -0.599% | 30.370% |
| iShares Nikkei 225® | 6.584% | 4.336% | 49.372% |
| iShares S&P 500 | 1.930% | -0.507% | 24.257% |
Comments by StockNews_com for this prediction
In the thread Evoke Pharma Inc. diskutieren
Evoke Pharma, Inc. (NASDAQ: EVOK) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for EVOK provided by MarketBeat
In the thread Trading Evoke Pharma Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten

